Cheil Bio Co

Cheil Bio Co ROIC

Delisted·Feb 25, 2026

The Return on Invested Capital (ROIC) of Cheil Bio Co (052670.KQ) as of Nov 17, 2026 is -4.62 %. In the previous year, Return on Invested Capital (ROIC) was -5.16 % — a change of -10.40% (higher).

ROIC

-4.62 %

YoY

-10.40%

Last updated:

Return on Invested Capital (ROIC) of Cheil Bio Co is 2023 -4.62 % . Return on Invested Capital (ROIC) of Cheil Bio Co was 2022 -5.16 % . It decreases by -10.40% higher compared to the previous year.

The Cheil Bio Co ROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROIC
Date
ROIC
Jan 1, 2016
2.87 KRW
Jan 1, 2017
2.55 KRW
Jan 1, 2018
3.50 KRW
Jan 1, 2019
6.45 KRW
Jan 1, 2020
2.60 KRW
Jan 1, 2021
-1.91 KRW
Jan 1, 2022
-5.16 KRW
Jan 1, 2023
-4.62 KRW
The Cheil Bio Co ROIC history
YEARROICYoY
-4.62 %-10.40%
-5.16 %+170.39%
-1.91 %-173.36%
2.60 %-59.67%
6.45 %+84.07%
3.50 %+37.41%
2.55 %-11.21%
2.87 %+20.80%
2.38 %-55.15%
5.30 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cheil Bio Co Stock analysis

What does Cheil Bio Co do? Cheil Bio Co., Ltd. generates revenue through the production and sale of veterinary products for pigs, cattle, chickens, cows, and aquatic animals. The company offers antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, and diagnostic kits including ELISA test kits, virus test kits, and DNA kits. These products are primarily sold to the domestic market, targeting livestock farmers and veterinary clinics. The firm also provides feed additives as part of its product portfolio. The company's product range includes specialized solutions for cattle, pigs, chickens, pets, and other animals, with a focus on health management and disease prevention. Veterinary clinics and livestock farms form the core customer segments, purchasing antibiotics, vaccines, and diagnostic tools to maintain animal health. The domestic market remains the primary sales channel, with no mention of international distribution. Cheil Bio's offerings are designed to address common health challenges in livestock, such as infections and parasitic infestations, through both preventive and therapeutic products. The inclusion of diagnostic kits like ELISA and DNA tests supports advanced veterinary care, enhancing the company's value proposition for professional animal health providers. Cheil Bio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cheil Bio Co stock

Return on Invested Capital (ROIC) of Cheil Bio Co is -4.62 % in 2023.

Return on Invested Capital (ROIC) of Cheil Bio Co changed from -5.16 % to -4.62 %, representing a -10.40% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Invested Capital (ROIC) Cheil Bio Co since 2006 – with annual values, charts, and detailed analysis.

ROIC measures how effectively a company uses its invested capital to generate profits. A ROIC above the cost of capital creates shareholder value.

ROIC = NOPAT / Invested Capital

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Invested Capital (ROIC)'s Cheil Bio Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Invested Capital (ROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Invested Capital (ROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Cheil Bio Co

All Key Metrics — Cheil Bio Co